Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results

Rhea-AI Summary

Kestra Medical Technologies (Nasdaq: KMTS) will report second quarter fiscal 2026 financial results on Thursday, December 11, 2025. Management will host a conference call at 4:30 p.m. Eastern Time with a live and archived webcast available in the investor relations "Events" section. Participants are encouraged to register on the website at least 10 minutes prior to the call start.

News Market Reaction – KMTS

+12.21% 5.3x vol

47 alerts

+12.21% Session close to close

+12.7% Peak in 4 hr 59 min

$1.39B Market Cap

5.3x Rel. Volume

In the Dec 3 session, KMTS gained 12.21%, reflecting a significant positive market reaction. Argus tracked a peak move of +12.7% during that session. Our momentum scanner triggered 47 alerts that day, indicating elevated trading interest and price volatility. Trading volume was exceptionally heavy at 5.3x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +12.2% in the session following this news. A strong positive reaction aligns with K...

Analysis

The stock surged +12.2% in the session following this news. A strong positive reaction aligns with KMTS trading above its 200-day MA at $21.57 and near the upper half of its 52-week range, with the stock already about 16.97% below its 52-week high. Past news shows sharp moves around offerings and preliminary results, indicating sensitivity to capital and growth updates. Investors have also reacted to clinical milestones, so earnings commentary and any forward-looking detail could have influenced sustainability of upside moves.

Key Figures

Earnings date: December 11, 2025 Conference call time: 4:30 p.m. Eastern Time Call registration lead time: 10 minutes

3 metrics

Earnings date December 11, 2025 Scheduled Q2 FY2026 financial results release

Conference call time 4:30 p.m. Eastern Time Management Q2 FY2026 results call

Call registration lead time 10 minutes Suggested early registration before conference call start

Historical Context

5 past events · Latest: Dec 03 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Dec 03	Earnings date set	Neutral	+12.2%	Scheduled Q2 FY2026 results release and conference call details.
Dec 02	Equity offering priced	Negative	-6.8%	Upsized common share offering priced with defined size and proceeds.
Dec 01	Equity offering launch	Negative	-8.5%	Proposed underwritten public offering of common shares announced.
Dec 01	Prelim earnings update	Positive	-8.5%	Preliminary Q2 FY2026 results with strong growth and margin gains.
Nov 10	Clinical study data	Positive	+0.8%	ACE-PAS real-world ASSURE study showed strong safety and effectiveness.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history shows negative reactions to equity offerings and even a sell-off on strong preliminary Q2 results, while today’s simple earnings-date notice coincided with a sharp gain.

Recent Company History

Over the last month, KMTS reported preliminary Q2 FY2026 results with strong revenue growth and margin expansion on Dec 1, 2025, yet the stock fell following that release and the concurrent offering announcements. Subsequent offering pricing on Dec 2 also saw further weakness. In contrast, the Dec 3 notice setting the formal Q2 FY2026 reporting date and conference call aligned with a 12.21% gain. Earlier in November, publication of large real-world ASSURE study data produced a modest positive move.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

KIRKLAND, Wash., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report second quarter fiscal 2026 financial results on Thursday, December 11. Management will host a corresponding conference call at 4:30 p.m. Eastern Time.

A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website. Participants are encouraged to register on the website 10 minutes prior to the start of the conference call.

About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact
Neil Bhalodkar
neil.bhalodkar@kestramedical.com

FAQ

When will Kestra Medical Technologies (KMTS) report Q2 fiscal 2026 results?

Kestra Medical Technologies (Nasdaq: KMTS) will report Q2 fiscal 2026 results on Thursday, December 11, 2025.

What time is the KMTS Q2 fiscal 2026 conference call on December 11, 2025?

The company will host a conference call at 4:30 p.m. Eastern Time on that date.

How can investors access the KMTS December 11, 2025 webcast and replay?

A live and archived webcast will be available in the investor relations "Events" section on the company website.

Do I need to register to join the KMTS December 11, 2025 conference call?

Participants are encouraged to register on the investor relations website 10 minutes prior to the call start.

Will the KMTS Q2 fiscal 2026 call include management commentary?

Management will host the conference call, which typically includes discussion of financial results and business updates.